Eli Lilly › Great businesses have a habit of remaining so even when market volatility arises. The stock market is cyclical, ...

Shares in Novo Nordisk fell as much as 6% on Friday before recovering some ground later in the session, extending recent ...

France's CAC 40 fell 1.8%, and Germany's DAX dropped 1.7%, underlining the significant impact the new measures are having across Europe's largest economies.

Novo Nordisk is a healthcare stock that is down 50% in 2025. Is NVO stock undervalued at current levels or can it move lower ...

Palantir Technologies has secured an agreement with the U.S. Army that could be worth up to $10 billion over the next decade, marking one of the largest software contracts in Defense Department ...

Trump's tariffs went live overnight at midnight and there were a few surprises. For example, tariffs on Canada were hiked ...

The FDA had set an Aug. 19 target action date for the company's application, which was seeking a green light for Eylea HD for the treatment of macular edema following retinal vein occlusion and for ...

Eli Lilly is set to report Q2 2025 earnings on August 7, with consensus expecting $14.4 billion in revenue and $5.56 EPS, up 30-42% YoY. Learn more on LLY stock here.

C OPENHAGEN: Shares in Novo Nordisk fell as much as 6% today to their lowest since August 2021, extending recent losses to ...

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.

European pharma stocks fell after President Trump [wrote to 17 companies]( ...

At their peak last year, one share in the company Novo Nordisk cost $142; now, they can be bought for under $50.